Page last updated: 2024-09-04

moxifloxacin and Cholera Infantum

moxifloxacin has been researched along with Cholera Infantum in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ji, S; Wang, N; Yang, W; Zhang, Y; Zhao, X; Zhu, L	1
Hampel, B; Lippert, H; Muehlhofer, E; Reimnitz, P; Weiss, G	1

Trials

2 trial(s) available for moxifloxacin and Cholera Infantum

Article	Year
Population pharmacokinetics of intravenous moxifloxacin 400 mg once-daily dosage in infected patients. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:10 Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Male; Middle Aged; Models, Theoretical; Moxifloxacin; Nonlinear Dynamics; Prospective Studies; Respiratory Tract Infections; Urinary Tract Infections; Young Adult	2014
Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study). Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2 Topics: Abdominal Abscess; Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Appendicitis; Aza Compounds; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Intestinal Perforation; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Peritonitis; Prospective Studies; Quinolines	2009

Article

Year

Population pharmacokinetics of intravenous moxifloxacin 400 mg once-daily dosage in infected patients.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:10

Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Male; Middle Aged; Models, Theoretical; Moxifloxacin; Nonlinear Dynamics; Prospective Studies; Respiratory Tract Infections; Urinary Tract Infections; Young Adult

2014

Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).

Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2

Topics: Abdominal Abscess; Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Appendicitis; Aza Compounds; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Intestinal Perforation; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Peritonitis; Prospective Studies; Quinolines

2009

Other Studies

1 other study(ies) available for moxifloxacin and Cholera Infantum

Article	Year
Gatifloxacin and moxifloxacin: two new fluoroquinolones. The Medical letter on drugs and therapeutics, 2000, Feb-21, Volume: 42, Issue:1072 Topics: Anti-Infective Agents; Aza Compounds; Community-Acquired Infections; Fluoroquinolones; Gastrointestinal Diseases; Gatifloxacin; Humans; Moxifloxacin; Pneumonia; Quinolines; Staphylococcus aureus	2000